Abstract
Fourteen Corynebacterium coyleae isolates were recovered from 12 in-patients during a 5-years period. In six patients, the isolates were considered as clinically significant, three definite (sepsis), two probable (sepsis and soft tissue infection), and one possible (post-transfusional bacteremia). In the remaining 6 patients (all neonatal bacteremias), there was not enough data for considering the isolates as clinical significant. API Coryne™ identified all isolates as C. jeikeium, while Biolog GP2™ correctly identified 7 out of the 14 isolates. Definitive identification was achieved in all isolates by the sequencing of a fragment of 724 to 1423 pb of 16S rDNA. Successive isolations from two patients presented identical random amplified polymorphic DNA (RAPD) profiles. All of the isolates were in-vitro-sensitive to β-lactams, gentamicin, rifampin, tetracycline, vancomycin, linezolid, and resistant to clindamycin. Resistance to erythromycin occurred in 83.3% of isolates, all of them presenting phenotype cMLS and harboring the gene ermX.
Similar content being viewed by others
References
Funke G, Ramos CP, Collins MD (1997) Corynebacterium coyleae sp. nov., isolated from human clinical specimens. Int J Syst Bacteriol 47:92–96
Funke G, von Graevenitz A, Clarridge JE 3rd, Bernard KA (1997) Clinical microbiology of coryneform bacteria. Clin Microbiol Rev 10:125–159
Soriano F (1987) Emergence of urea-splitting multi-resistant coryneform bacteria (Corynebacterium group D2) as pathogens. Eur J Clin Microbiol 6:601–602
Coyle MB, Lipsky BA (1990) Coryneform bacteria in infectious diseases: clinical and laboratory aspects. Clin Microbiol Rev 3:227–246
Tanner MA, Shoskes D, Shahed A, Pace NR (1999) Prevalence of corynebacterial 16S rRNA sequences in patients with bacterial and “nonbacterial” prostatitis. J Clin Microbiol 37:1863–1870
Bernard KA, Munro C, Wiebe D, Ongsansoy E (2002) Characteristics of rare or recently described Corynebacterium species recovered from human clinical material in Canada. J Clin Microbiol 40:4375–4381
Bernard KA (2005) Corynebacterium species and coryneforms: an update on taxonomy and diseases attributed to these taxa. Clin Microbiol Newsl 27:9–18
Fernández-Natal MI, Guerra JM, Alcoba M, Cachón F, Soriano F (2001) Bacteremia caused by multiply resistant Corynebacterium urealyticum: six case reports and review. Eur J Clin Microbiol Infect Dis 20:514–517
Soriano F, Ponte C, Ruiz R, Zapardiel J (1993) Non-urinary tract infections caused by multiply antibiotic-resistant Corynebacterium urealyticum. Clin Infect Dis 17:890–891
Funke G, Bernard KA (2007) Coryneform gram-positive rods. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (eds) Manual of clinical microbiology, 9th edn. American Society for Microbiology, Washington, DC, pp 485–514
Renaud FN, Coustumier AL, Wilhem N, Aubel D, Riegel P, Bollet C, Freney J (2007) Corynebacterium hansenii sp. nov., an alpha-glucosidase-negative bacterium related to Corynebacterium xerosis. Int J Syst Evol Microbiol 57:1113–1116
Yassin AF (2007) Corynebacterium ureicelerivorans sp. nov., a lipophilic bacterium isolated from blood culture. Int J Syst Evol Microbiol 57:1200–1203
Hollis DG, Weaver RE (1981) Gram-positive organisms: a guide to identification. Special Bacteriology Section, Centers for Disease Control, Atlanta, Georgia
Riegel P, de Briel D, Prévost G, Jehl F, Monteil H (1994) Genomic diversity among Corynebacterium jeikeium strains and comparison with biochemical characteristics and antimicrobial susceptibilities. J Clin Microbiol 32:1860–1865
Renaud FN, Dutaur M, Daoud S, Aubel D, Riegel P, Monget D, Freney J (1998) Differentiation of Corynebacterium amycolatum, C. minutissimum, and C. striatum by carbon substrate assimilation tests. J Clin Microbiol 36:3698–3702
Funke G, Renaud FN, Freney J, Riegel P (1997) Multicenter evaluation of the updated and extended API (RAPID) Coryne database 2.0. J Clin Microbiol 35:3122–3126
Lindenmann K, von Graevenitz A, Funke G (1995) Evaluation of the Biolog system for the identification of asporogenous, aerobic gram-positive rods. Med Microbiol Lett 4:287–296
Wauters G, van Bosterhaud B, Janssens M, Verhaegen J (1998) Identification of Corynebacterium amycolatum and other nonlipophilic fermentative corynebacteria of human origin. J Clin Microbiol 26:1430–1432
Drancourt M, Bollet C, Carlioz A, Martelin R, Gayral JP, Raoult D (2000) 16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates. J Clin Microbiol 38:3623–3630
Fekete A, Bantle JA, Halling SM, Stich RW (1992) Amplification fragment length polymorphism in Brucella strains by use of polymerase chain reaction with arbitrary primers. J Bacteriol 174:7778–7783
Clinical and Laboratory Standards Institute (CLSI) (2007) Methods for Antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline. CLSI document M45-A (ISBN 1-56238-607-7). CLSI, Wayne, Pennsylvania
Seppälä H, Nissinen A, Yu Q, Huovinen P (1993) Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 32:885–891
Rosato AE, Lee BS, Nash KA (2001) Inducible macrolide resistance in Corynebacterium jeikeium. Antimicrob Agents Chemother 45:1982–1989
Taguchi M, Nishikawa S, Matsuoka H, Narita R, Abe S, Fukuda K, Miyamoto H, Taniguchi H, Otsuki M (2006) Pancreatic abscess caused by Corynebacterium coyleae mimicking malignant neoplasm. Pancreas 33:425–429
Bosshard PP, Abels S, Zbinden R, Böttger EC, Altwegg M (2003) Ribosomal DNA sequencing for identification of aerobic Gram-positive rods in the clinical laboratory (an 18-month evaluation). J Clin Microbiol 41:4134–4140
Funke G, Nietznik C (2005) Minimal inhibitory concentrations of linezolid against clinical isolates of coryneform bacteria. Eur J Clin Microbiol Infect Dis 24:612–614
Funke G, Troxler R (2005) In vitro activity of quinupristin and dalfopristin in combination and alone against coryneform bacteria. Eur J Clin Microbiol Infect Dis 24:769–771
Soriano F, Fernández-Roblas R, Calvo R, García-Calvo G (1998) In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials. Antimicrob Agents Chemother 42:1028–1033
Yagüe G, Mora B, Martínez-Toldos MC, Rodríguez T, Valero-Guillén PL, Segovia M (2005) Implicación de los genes ermX en la resistencia a los macrólidos y la telitromicina de Corynebacterium jeikeium y Corynebacterium amycolatum. Rev Esp Quimioterap 18:236–242
Acknowledgments
This study has been supported by the Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Madrid, Spain, research project 03/0534.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fernández-Natal, M.I., Sáez-Nieto, J.A., Fernández-Roblas, R. et al. The isolation of Corynebacterium coyleae from clinical samples: clinical and microbiological data. Eur J Clin Microbiol Infect Dis 27, 177–184 (2008). https://doi.org/10.1007/s10096-007-0414-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-007-0414-1